Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,329,822
-
Share change
-
-356,679
-
Total reported value
-
$1,736,442
-
Put/Call ratio
-
0.4%
-
Price per share
-
$0.33
-
Number of holders
-
37
-
Value change
-
-$121,351
-
Number of buys
-
8
-
Number of sells
-
16
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q2 2023
As of 30 Jun 2023,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,329,822 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Penserra Capital Management LLC, MILLENNIUM MANAGEMENT LLC, TWO SIGMA ADVISERS, LP, STATE STREET CORP, NORTHERN TRUST CORP, and Bernardo Wealth Planning LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.